Cell and Gene Therapy, Industrial Impact

State of the Global Biotech Landscape: Where the Opportunities Lie

December 13, 2022

State of the Global
Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth. The analysis period (2017-2022) encompasses a unique timeframe including the global COVID-19 pandemic.

Spotlight

LEE BIOSOLUTIONS, INC

Lee Biosolutions Inc. is a global biotech healthcare company producing highly purified enzymes and related proteins that are critical raw materials used in research and commercial clinical diagnostic applications. Our research and manufacturing facility along with our scientific team’s extensive expertise with protein purification has led to increased growth opportunities for the company in areas of endocrine, inflammation, coagulation, oncology, cardiovascular and autoimmune disease markets.

OTHER WHITEPAPERS
news image

Quality Control Solutions for Cell and Gene Therapy

whitePaper | September 10, 2022

Droplet Digital PCR (ddPCR) provides highly precise and absolute quantification of nucleic acids by counting nucleic acid molecules encapsulated in discrete water-in-oil droplets.

Read More
news image

Growing a circular economy with fungalbiotechnology

whitePaper | October 22, 2022

Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans

Read More
news image

BIOPHARMACEUTICAL INDUSTRY AND INTERRELATED BIOTECHNOLOGY ORGANIZATIONS

whitePaper | November 21, 2019

Our Accounting and Finance team has published an overview of the accounting and finance challenges facing the Biopharmaceutical industry and interrelated Biotechnology organizations.

Read More
news image

Antibodies to Viral Vectors Responding to Demands toSimplify Progress in Bioprocessing

whitePaper | March 16, 2023

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Read More
news image

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Read More
news image

Leveraging innovations in plasmid manufacturing to bring advanced therapies to market

whitePaper | December 13, 2022

The global demand for plasmid DNA has increased dramatically in recent years, fueled by a surge in the clinical development of next-generation cell and gene therapy products and more recently by the success of COVID-19 vaccines.

Read More

Spotlight

LEE BIOSOLUTIONS, INC

Lee Biosolutions Inc. is a global biotech healthcare company producing highly purified enzymes and related proteins that are critical raw materials used in research and commercial clinical diagnostic applications. Our research and manufacturing facility along with our scientific team’s extensive expertise with protein purification has led to increased growth opportunities for the company in areas of endocrine, inflammation, coagulation, oncology, cardiovascular and autoimmune disease markets.

Events